Literature DB >> 20945153

Physicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.

Oksana Tsinman1, Konstantin Tsinman, Na Sun, Alex Avdeef.   

Abstract

PURPOSE: To mimic the physicochemical selectivity of the blood-brain barrier (BBB) and to predict its passive permeability using a PAMPA model based on porcine brain lipid extract (PBLE 10%w/v in alkane).
METHODS: Three PAMPA (BD pre-coated and PBLE with 2 different lipid volumes) models were tested with 108 drugs. Abraham solvation descriptors were used to interpret the in vitro-in vivo correlation with 282 in situ brain perfusion measurements, spanning over 5 orders of magnitude. An in combo PAMPA model was developed from combining measured PAMPA permeability with one H-bond descriptor.
RESULTS: The in combo PAMPA predicted 93% of the variance of 197 largely efflux-inhibited in situ permeability training set. The model was cross-validated by the "leave-many-out" procedure, with q(2) = 0.92 ± 0.03. The PAMPA models indicated the presence of paramembrane water channels. Only the PBLE-based PAMPA-BBB model with sufficient lipid to fill all the internal pore space of the filter showed a wide dynamic range window, selectivity coefficient near 1, and was suitable for predicting BBB permeability.
CONCLUSION: BBB permeability can be predicted by in combo PAMPA. Its speed and substantially lower cost, compared to in vivo measurements, make it an attractive first-pass screening method for BBB passive permeability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20945153      PMCID: PMC3034772          DOI: 10.1007/s11095-010-0280-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  85 in total

1.  Analgesics and their antagonists: some steric and chemical considerations. I. The dissociation constants of some tertiary amines and synthetic analgesics, the conformations of methadone-type compounds.

Authors:  A H BECKETT
Journal:  J Pharm Pharmacol       Date:  1956-11       Impact factor: 3.765

2.  PAMPA--a drug absorption in vitro model 8. Apparent filter porosity and the unstirred water layer.

Authors:  Per E Nielsen; Alex Avdeef
Journal:  Eur J Pharm Sci       Date:  2004-05       Impact factor: 4.384

3.  PAMPA--a drug absorption in vitro model 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates.

Authors:  Alex Avdeef; Per E Nielsen; Oksana Tsinman
Journal:  Eur J Pharm Sci       Date:  2004-08       Impact factor: 4.384

4.  Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.

Authors:  Alex Avdeef; Per Artursson; Sibylle Neuhoff; Lucia Lazorova; Johan Gråsjö; Staffan Tavelin
Journal:  Eur J Pharm Sci       Date:  2005-01-20       Impact factor: 4.384

5.  QSAR modeling of the blood-brain barrier permeability for diverse organic compounds.

Authors:  Liying Zhang; Hao Zhu; Tudor I Oprea; Alexander Golbraikh; Alexander Tropsha
Journal:  Pharm Res       Date:  2008-06-14       Impact factor: 4.200

6.  New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy.

Authors:  C Rousselle; P Clair; J M Lefauconnier; M Kaczorek; J M Scherrmann; J Temsamani
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

7.  Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.

Authors:  N H Greig; T T Soncrant; H U Shetty; S Momma; Q R Smith; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.

Authors:  W M Pardridge; D Triguero; J Yang; P A Cancilla
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

9.  Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.

Authors:  Jurgen Mensch; Anouche Melis; Claire Mackie; Geert Verreck; Marcus E Brewster; Patrick Augustijns
Journal:  Eur J Pharm Biopharm       Date:  2010-01-11       Impact factor: 5.571

10.  In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier.

Authors:  Salvatore Cisternino; Christophe Rousselle; Marcel Debray; Jean-Michel Scherrmann
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

View more
  14 in total

1.  Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma.

Authors:  Wen-Bin Yang; Che-Chia Hsu; Tsung-I Hsu; Jing-Ping Liou; Kwang-Yu Chang; Pin-Yuan Chen; Jr-Jiun Liu; Shung-Tai Yang; Jia-Yi Wang; Shiu-Hwa Yeh; Ruei-Ming Chen; Wen-Chang Chang; Jian-Ying Chuang
Journal:  Neuro Oncol       Date:  2020-10-14       Impact factor: 12.300

Review 2.  Physiologically based pharmacokinetic modelling of drug penetration across the blood-brain barrier--towards a mechanistic IVIVE-based approach.

Authors:  Kathryn Ball; François Bouzom; Jean-Michel Scherrmann; Bernard Walther; Xavier Declèves
Journal:  AAPS J       Date:  2013-06-20       Impact factor: 4.009

3.  A new in situ brain perfusion flow correction method for lipophilic drugs based on the pH-dependent Crone-Renkin equation.

Authors:  Alex Avdeef; Na Sun
Journal:  Pharm Res       Date:  2010-11-02       Impact factor: 4.200

Review 4.  Blood-brain barrier structure and function and the challenges for CNS drug delivery.

Authors:  N Joan Abbott
Journal:  J Inherit Metab Dis       Date:  2013-04-23       Impact factor: 4.982

5.  A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations.

Authors:  Timothy S Carpenter; Daniel A Kirshner; Edmond Y Lau; Sergio E Wong; Jerome P Nilmeier; Felice C Lightstone
Journal:  Biophys J       Date:  2014-08-05       Impact factor: 4.033

Review 6.  Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.

Authors:  Noora Sjöstedt; Hanna Kortejärvi; Heidi Kidron; Kati-Sisko Vellonen; Arto Urtti; Marjo Yliperttula
Journal:  Pharm Res       Date:  2014-01       Impact factor: 4.200

7.  Blood-Brain Barrier Permeability Study of Potential Neuroprotective Compounds Recovered From Plants and Agri-Food by-Products.

Authors:  José David Sánchez-Martínez; Alberto Valdés; Rocio Gallego; Zully Jimena Suárez-Montenegro; Marina Alarcón; Elena Ibañez; Gerardo Alvarez-Rivera; Alejandro Cifuentes
Journal:  Front Nutr       Date:  2022-06-16

8.  Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

Authors:  Scott D Campbell; Karen J Regina; Evan D Kharasch
Journal:  J Biomol Screen       Date:  2013-08-14

9.  Limited Impact of Murine Placental MDR1 on Fetal Exposure of Certain Drugs Explained by Bypass Transfer Between Adjacent Syncytiotrophoblast Layers.

Authors:  Arimi Fujita; Saki Noguchi; Rika Hamada; Satoko Inoue; Tsutomu Shimada; Satomi Katakura; Tetsuo Maruyama; Yoshimichi Sai; Tomohiro Nishimura; Masatoshi Tomi
Journal:  Pharm Res       Date:  2022-01-26       Impact factor: 4.580

10.  Predicting apparent passive permeability of Caco-2 and MDCK cell-monolayers: A mechanistic model.

Authors:  Kai Bittermann; Kai-Uwe Goss
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.